88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

Haisco enters into Exclusive License Agreement with new US venture founded by Population Health Partners and ARCH Venture Partners BEIJING , Aug. 25, 2026 /PRNewswire/ -- On August 25, Haisco Pharmaceutical Group Co., Ltd. ("Haisco") (Ticker Code: 002653) announced that it has entered into an exclusive licensing ... 2026-08-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities EAST RUTHERFORD, N.J. , Aug. 25, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the successful completion of three Pre-Approval ... 2026-08-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027 TAIPEI , Aug. 25, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced that it has completed enrollment in its Phase 1b expansion trial evaluating pidnarulex (CX-5461) monotherapy ... 2026-08-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Classys Nears 50,000 Devices Sold Globally as Full-Lineup Growth Accelerates Expands global portfolio beyond HIFU and MRF to include MNRF, laser, and dermabrasion devices, strengthening its medium- to long-term growth foundation 1H26 Exports, excluding shipments to its ... 2026-08-25T Cosmetics & Personal Care Medical Equipment Medical/Pharmaceuticals
ICP DAS-BMP Brings Advanced Medical TPU Portfolio to Medical Manufacturing Asia 2026 HSINCHU , Aug. 25, 2026 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), will exhibit at Medical Manufacturing ... 2026-08-25T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases SHANGHAI and HONG KONG , Aug. 25, 2026 /PRNewswire/ -- Antengene Corporation Limited (" Antengene ", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company ... 2026-08-25T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership Group total revenue increased to RMB 3,701.4 million, representing 37.0% period-over-period growth on an AER [1] basis (41.5% growth on a CER [2] basis) Gross profit grew by 40.6% period-over-period, ... 2026-08-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform" Development of Leptin receptor-based technology and hybrid LNP platform Combining Blood-Brain Barrier penetration and a one-month sustained-release formulation in a single structure, with potential ... 2026-08-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
INDONESIAN HEALTHCARE TRAVEL TO MALAYSIA HITS RECORD RM2.2 BILLION AS MHX RETURNS TO YOGYAKARTA YOGYAKARTA, Indonesia , Aug. 24, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) once again strengthened Malaysia's presence in Indonesia through MHX Yogyakarta 2026, held from 20 to 23 ... 2026-08-24T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy HM17321, a proprietary UCN2 (urocortin-2) analog, is being developed as a treatment for chronic-weight management and associated conditions, including obesity Total deal value of up to $2.3 billion, ... 2026-08-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved